These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 27143430)

  • 1. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
    Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
    Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of TREML2 in Alzheimer's Disease.
    Wang SY; Gong PY; E Y; Zhang YD; Jiang T
    J Alzheimers Dis; 2020; 76(3):799-806. PubMed ID: 32568208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models.
    Karanfilian L; Tosto MG; Malki K
    Neurobiol Aging; 2020 Feb; 86():39-53. PubMed ID: 31727362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
    Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
    J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
    Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
    Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
    Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
    Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
    J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 dependent and independent functions of microglia in Alzheimer's disease.
    Hou J; Chen Y; Grajales-Reyes G; Colonna M
    Mol Neurodegener; 2022 Dec; 17(1):84. PubMed ID: 36564824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.
    Zhao Y; Wu X; Li X; Jiang LL; Gui X; Liu Y; Sun Y; Zhu B; Piña-Crespo JC; Zhang M; Zhang N; Chen X; Bu G; An Z; Huang TY; Xu H
    Neuron; 2018 Mar; 97(5):1023-1031.e7. PubMed ID: 29518356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of FAK/Rac1/Cdc42-GTPase signaling ameliorates impaired microglial migration response to Aβ
    Rong Z; Cheng B; Zhong L; Ye X; Li X; Jia L; Li Y; Shue F; Wang N; Cheng Y; Huang X; Liu CC; Fryer JD; Wang X; Zhang YW; Zheng H
    FASEB J; 2020 Aug; 34(8):10984-10997. PubMed ID: 32613609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 Attenuates Aβ1-42-Mediated Neuroinflammation in BV-2 Cells by Downregulating TLR Signaling.
    Long H; Zhong G; Wang C; Zhang J; Zhang Y; Luo J; Shi S
    Neurochem Res; 2019 Aug; 44(8):1830-1839. PubMed ID: 31134514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
    Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
    Front Immunol; 2020; 11():559342. PubMed ID: 33101276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
    Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
    ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.
    Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT
    Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.
    Jiang T; Yu JT; Zhu XC; Tan MS; Gu LZ; Zhang YD; Tan L
    Neurobiol Aging; 2014 Jun; 35(6):1243-51. PubMed ID: 24368090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.